Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with diabetes are those whose fasting glucose levels are more than or equal to 126 mg/dl, their random blood glucose levels are more than or equal to 200 mg/dl, their HbA1c is more than or equal to 6.5%, their 2-hour blood glucose on a 75-gram oral glucose tolerance test (OGTT) is more than or equal to 200 mg/dl, or they are currently receiving hypoglycemic medication.
Exclusion criteria
Exclusion criteria: •Pregnant or planning for pregnancy, breastfeeding mother •Enrolled in other clinical trials •Have active malignancy or are under investigation for malignancy •Have a history of any of the following medical conditions- ?Cushing syndrome ?HIV ?Chronic kidney disease (CKD) ?Chronic liver disease ?Hyperthyroidism ?Alcohol and/or substance abuse. •Currently taking any of the following medications- ?Psychiatric medication ?Anti-diabetic medication ?Weight-loss medication ?Oral steroids •Unable to participate due to other factors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the hypoglycemic effect of test drug by monitoring the FBS, PPBS of the diabetic patients suffering from type-2 diabetes mellitus.Timepoint: 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of test drug on quality of life among the patients suffering from type-2 diabetes mellitus.Timepoint: 28 days | — |
Countries
India
Contacts
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital